DIRUI Successfully Hosts RIQAS Webinar

Date of publication：2024-06-30 22:08:13

DIRUI, as one of the leading in vitro diagnostic companies in China, believes in producing high quality product that can help streamline procedures, whilst saving time and money for laboratories of all sizes and budgets.

In the clinical laboratory, Quality Control (QC) refers to the process of detecting analytical errors to ensure both the reliability and accuracy of patient test results. Poor performance can result in misdiagnosis, delayed/inappropriate treatment, increased costs and may even be potentially life threatening for the patient. External Quality Assessment (EQA) provides a means of assessing the analytical performance of a laboratory compared to other laboratories utilizing the same methods and instruments. Therefore, it is essential to conduct EQA for all laboratories to assure result accuracy.

Since 2015, DIRUI has closely collaborated with Randox on various RIQAS programs which includes Urinalysis, Immunoassay, General Clinical Chemistry, Haematology and Coagulation. By the end of 2023, our Urinalysis H Series instruments were ranked 3rd in this EQA after Siemens and Roche, accounting for more than 1/10 of all participating urinalysis analyzers in the RIQAS program.

Certificate of Participation (Urinalysis Program)

RIQAS (Randox International Quality Assessment Scheme) is the world's largest international EQA scheme, with participation from over 76,200 laboratories in 145 countries. RIQAS offers laboratories a comprehensive and cost-effective EQA solution that helps meet regulatory requirements and ensures the reliability and accuracy of patient test results.

To further expand the knowledge and understanding of EQA and QC practices, in June 2024, DIRUI organized a webinar on the topic of "Interpretation and Application of RIQAS Report."

Randox manager Stephen Doherty was invited to present on the importance of EQA in the laboratories and to provide laboratories some great advice on EQA to improve DIRUI’s laboratory testing. This "solution-oriented" webinar attracted a large audience of DIRUI, DIRUI’s global partners, distributors and KOL experts by providing valuable insights.

RIQAS Report

During the webinar, participants engaged in in-depth discussions with Stephen, addressing real-life scenarios and solutions encountered during use. Stephen's clear and insightful responses provided participants with valuable experience and new ideas for their future work.

The successful hosting of this webinar provided participants with a wealth of knowledge and experience sharing, further solidifying DIRUI's customer-centric philosophy and focus on product quality.

In addition to participating in RIQAS, DIRUI also actively participates in other internationally recognized EQA programs such as CAP UAA and CMP for urinalysis to ensure the performance and continuous improvement of its instruments.

By collaborating with more internationally renowned institutions, DIRUI will continue to strive to improve our product quality and ensure that our customers receive the highest quality service and the most reliable test results. We look forward to future cooperation and co-innovation to make greater contributions to the global IVD industry.

Last article：DIRUI obtains IVDR certification, making another leap forward Next articleJoin DIRUI at ADLM 2024

Dirui News